Imprinting disorders

Area of Science:

• Genetics
• Developmental Biology
• Pediatrics

Background:

• Imprinting disorders (ImpDis) are congenital conditions resulting from disruptions in genomic imprinting.
• Common examples include Prader-Willi syndrome, Angelman syndrome, and Beckwith-Wiedemann syndrome, often presenting with non-specific symptoms like growth disturbances and developmental delay.
• Diagnosis is challenging due to the heterogeneity and overlap of clinical features.

Purpose of the Study:

• To explore the mechanisms underlying imprinting disorders (ImpDis) and imprinting defects (ImpDefs).
• To identify the impact of defects in differentially methylated regions (DMRs) on imprinted gene expression.
• To provide insights into the pathophysiology and potential therapeutic strategies for ImpDis.

Main Methods:

• Analysis of genomic and imprinting defects (ImpDefs) affecting differentially methylated regions (DMRs).
• Investigation of monoallelic and parent-of-origin-specific gene expression.
• Identification of functional cross-talk between imprinted genes and pathways.

Main Results:

• Four types of genomic and imprinting defects (ImpDefs) affecting DMRs are identified as causes of ImpDis.
• These defects disrupt the normal parent-specific expression of imprinted genes.
• Functional cross-talk between imprinted genes and pathways offers insights into ImpDis pathophysiology.

Conclusions:

• Understanding ImpDis requires a multidisciplinary approach, integrating genetic, developmental, and clinical perspectives.
• Current treatments for ImpDis are symptomatic, with targeted and personalized therapies under development.
• Further research into DMR regulation and gene interactions is crucial for improving diagnosis and treatment outcomes.